NCT01673503

Brief Summary

The purpose of this study is to compare visual acuity, safety, predictability, corneal biomechanics, dry eyes, and nerve-morphology after all femtosecond laser refractive lenticule extraction. Approximately 30 to 40 patients with moderate to high myopia will randomly (after ocular dominance) receive ReLEx flex in one eye, and ReLEx smile in the other.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at below P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2011

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

August 20, 2012

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 28, 2012

Completed
Last Updated

January 24, 2013

Status Verified

January 1, 2013

First QC Date

August 20, 2012

Last Update Submit

January 23, 2013

Conditions

Keywords

Myopiarefractive surgeryall femtosecond laserReLEx flexReLEx smile

Outcome Measures

Primary Outcomes (1)

  • Visual acuity

    Using ETDRS charts, both uncorrected and corrected distance visual acuity, along with visual acuity using the FrACT contrast chart

    up to 6 months

Secondary Outcomes (1)

  • refractive predictability

    Pre-surgery, 1 week, 1 month, 3 months, 6 months

Other Outcomes (1)

  • Corneal biomechanics, corneal nerve changes and dry eye symptoms

    pre-surgery and 6 months after

Study Arms (2)

Carl Zeiss Meditech VisuMax laser - ReLEx flex

ACTIVE COMPARATOR

\>30 patients will receive treatment for myopia with a VisuMax femtosecond laser from Carl Zeiss. The laser can cut with two different settings, called ReLEx flex and ReLEx smile. One eye will recieve ReLEx flex, and the other ReLEx smile

Device: Carl Zeiss Meditech VisuMax laser

Carl Zeiss Meditech VisuMax laser - ReLEx smile

ACTIVE COMPARATOR

\>30 patients will receive treatment for myopia with a VisuMax femtosecond laser from Carl Zeiss. The laser can cut with two different settings, called ReLEx flex and ReLEx smile. One eye will recieve ReLEx flex, and the other ReLEx smile

Device: Carl Zeiss Meditech VisuMax laser

Interventions

Refractive lenticule extraction (ReLEx) with the Carl Zeiss Meditech VisuMax laser

Also known as: Refractive lenticule extraction, ReLEx
Carl Zeiss Meditech VisuMax laser - ReLEx flexCarl Zeiss Meditech VisuMax laser - ReLEx smile

Eligibility Criteria

Age25 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • to 45 years,
  • moderate to high myopia with astigmatism =\< 2 D,
  • otherwise eye healthy,
  • CDVA of 0.8 or better (Snellen).

You may not qualify if:

  • systemic or ocular disease or previous eye surgery,
  • thin cornea,
  • a difference of more than 2 D myopia in the eyes of each subject.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Ophthalmology Aarhus Sygehus - Aarhus University Hospital, Denmark

Aarhus, 8000, Denmark

Location

Related Publications (1)

  • Vestergaard AH, Gronbech KT, Grauslund J, Ivarsen AR, Hjortdal JO. Subbasal nerve morphology, corneal sensation, and tear film evaluation after refractive femtosecond laser lenticule extraction. Graefes Arch Clin Exp Ophthalmol. 2013 Nov;251(11):2591-600. doi: 10.1007/s00417-013-2400-x. Epub 2013 Jun 22.

MeSH Terms

Conditions

MyopiaAstigmatism

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Study Officials

  • Anders H Vestergaard, MD

    Odense University Hospital, University of Southern Denmark

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD student

Study Record Dates

First Submitted

August 20, 2012

First Posted

August 28, 2012

Study Start

May 1, 2011

Last Updated

January 24, 2013

Record last verified: 2013-01

Locations